|Bid||514.67 x 900|
|Ask||516.79 x 800|
|Day's Range||514.59 - 524.27|
|52 Week Range||430.16 - 539.13|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||31.60|
|Earnings Date||Apr 24, 2023 - Apr 28, 2023|
|Forward Dividend & Yield||1.52 (0.29%)|
|Ex-Dividend Date||Feb 24, 2023|
|1y Target Est||579.00|
Subscribe to Yahoo Finance Plus to view Fair Value for CHE
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.
Chemed (CHE) records increases in drain cleaning, plumbing, excavation and water restoration revenues within the Roto-Rooter branch commercial business.
Here is how Bellicum Pharmaceuticals (BLCM) and Chemed (CHE) have performed compared to their sector so far this year.